Rheumatology Medical News about Fibromyalgia Hippocampus

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09

Wood P et al. – Fibromyalgia has been associated with disrupted hippocampal brain metabolite ratios by studies using single voxel magnetic resonance spectroscopy (1H–MRS). Exposure to stress is considered a risk factor for the development and exacerbation of fibromyalgia symptoms...This report details the case of a 47–year–old woman with fibromyalgia who was originally found to have a profound depression of the ratio of N–acetylaspartate to creatine in her right hippocampus during participation in a study to assess brain metabolite disturbances in fibromyalgia utilizing single voxel proton magnetic resonance spectroscopy. Clinical and spectroscopic evaluation following nine months of treatment demonstrated both an improvement in patient's clinical profile and normalization of the NAA/Cr ratio within her right hippocampus. Therapeutic strategies aimed at demonstrable lesions associated with fibromyalgia appear to represent rational targets for pharmacological intervention. The rationale for development of novel pharmacotherapies for this unusual disorder is discussed.

<< Previous
CD23 mediates anti-mycobacterial activity of human macrophages

Next >>
Financial Risk of the Biotech Industry versus the Pharmaceutical...